• Profile
Close

Achieving ventricular rate control in patients taking chronic beta-blocker therapy

The American Journal of Emergency Medicine Sep 15, 2017

Feeney ME, et al. - The authors assessed the difference in response to ventricular rate control with intravenous (IV) metoprolol compared to IV diltiazem in patients taking chronic beta-blocker therapy who present to the emergency department (ED) in atrial fibrillation (AF) with rapid ventricular rate (RVR). In patients in AF with RVR on chronic beta-blocker therapy, the use of IV diltiazem was correlated with a higher rate of successful response to rate control compared to IV metoprolol. However, the difference between groups was not statistically significant.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay